Theravance

Beleaguered Theravance logs head-to-head trial loss for Yupelri against Boehringer's Spiriva
Fierce Pharma
Sun, 01/7/24 - 04:07 pm
Theravance
Yupelri
COPD
Boehringer Ingelheim
Spiriva
Viatris and Theravance report data from COPD treatment trial
Clinical Trials Arena
Tue, 11/14/23 - 09:24 am
Viatris
Theravance
clinical trials
Yupelri
COPD
Irenic Capital urges Theravance to conduct review, add shareholder to board
NASDAQ
Tue, 02/28/23 - 09:59 am
Theravance
Irenic Capital
Theravance declares independence from GSK, crafts $250M plan to buy back its own shares
Endpoints
Mon, 09/19/22 - 09:09 am
Theravance
GSK
Theravance gets a fresh start
EP Vantage
Thu, 07/14/22 - 10:50 am
Theravance
GSK
Trelegy Ellipta
Royalty Pharma
Theravance Narrows Focus to Multiple System Atrophy Subset Following Mixed Results
BioSpace
Tue, 04/5/22 - 11:04 am
Theravance
ampreloxetine
multiple system atrophy
neurogenic orthostatic hypotension
End-of-Year Restructuring Means Layoffs for These Companies
BioSpace
Tue, 11/16/21 - 11:57 am
restructuring
Rigel Pharmaceuticals
Zymergen
Esperion Therapeutics
Amarin
Theravance
Sanofi
Acorda Therapeutics
CureVac
Ziopharm Oncology
Theravance axing 75% of staff, slashing R&D budget after flunking phase 3
Fierce Biotech
Wed, 09/15/21 - 11:01 am
Theravance
layoffs
R&D
clinical trials
Theravance takes a gut punch as J&J-partnered JAK drug flops key test in ulcerative colitis
Endpoints
Mon, 08/23/21 - 11:26 pm
Theravance
izencitinib
ulcerative colitis
Crohn’s disease
clinical trials
Theravance Biopharma doses first patient in phase 2 Covid-19 trial with JAKi inhibitor TD-0903
Pharmaceutical Business Review
Fri, 06/26/20 - 09:42 am
Theravance
COVID-19
clinical trials
acute lung injury
TD-0903
JP Morgan Preview: Small, Medium and Large, with a Lot of M&A Speculation
BioSpace
Mon, 01/13/20 - 11:08 am
JPMHC 2020
M&A
Exelixis
Intercept Pharmaceuticals
Avidity Biosciences
Theravance
Moderna Therapeutics
Kodiak Sciences
Pfizer Strikes JAK Inhibitor Deal Worth Up to $250 Million With Theravance
BioSpace
Mon, 12/23/19 - 11:52 pm
Pfizer
Theravance
JAK inhibitors
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/16/19 - 05:41 pm
FDA
Merck
Arqule
Affimed
BeiGene
Epizyme
MorphoSys
Theravance
Allena Pharma
Akero Therapeutics
Atreca
Dermavant Sciences
Personalis
Prevail Therapeutics
Stoke Therapeutics
IPOs
Layoffs Hit California Biopharma Companies
BioSpace
Mon, 02/18/19 - 11:49 am
layoffs
Roche
Genentech
Pfizer
Aduro BioTech
Theravance
Merck
Theravance Pipeline Strong, Plans Yupelri Launch by Year End
Yahoo/Zacks.com
Fri, 11/30/18 - 12:32 pm
Theravance
FDA
Yupelri
COPD
Mylan, Theravance win FDA approval for COPD drug
Biopharma Dive
Mon, 11/12/18 - 11:37 pm
Theravance
Mylan
Yupelri
COPD
FDA
FDA Action Alert: Theravance, Mallinckrodt and Aquestive
BioSpace
Mon, 11/12/18 - 09:21 am
FDA
Theravance
revefenacin
COPD
Mallinckrodt
MNK-812
Aquestive Therapeutics
AQST-199
erectile dysfunction
Theravance Biopharma and Cumberland Pharmaceuticals Enter into $25 Million Antibiotic Deal
Xtalks
Wed, 11/7/18 - 11:57 am
Cumberland Pharmaceuticals
Theravance
antibiotic
Vibativ
hospital-acquired bacterial pneumonia
Can Johnson & Johnson Replace Remicade for $100 Million Upfront?
Motley Fool
Wed, 02/21/18 - 09:40 am
JNJ
Remicade
TD-1473
Theravance
JAK inhibitors
inflammatory bowel disease
J&J strikes potential $1B JAK inhibitor deal with Theravance
Biopharma Dive
Wed, 02/7/18 - 10:06 am
JNJ
JAK inhibitors
Theravance
TD-1473
drug development
Crohn's Disease
ulcerative colitis

Pages